Transdigm Group INC Form 4 insider transactions
NYSE
Jessica L. Warren, GC, CCO, and Secretary of TransDigm Group INC, reports the acquisition and disposal of common stock and stock options on May 13, 2025.
NYSE
W. Nicholas Howley, a director at TransDigm Group INC, exercised stock options and sold shares on May 5, 2025, according to a recent SEC Form 4 filing.
NYSE
Joel Reiss, Co-Chief Operating Officer of TransDigm Group INC, exercised stock options and sold shares on April 21, 2025, according to a Form 4 filing with the SEC.
NYSE
TransDigm Group's CEO, Kevin Stein, exercised stock options and sold shares indirectly held through the Fortuna Trust under a pre-arranged 10b5-1 trading plan on April 14, 2025.
NYSE
Director W. Nicholas Howley exercised stock options and sold shares of TransDigm Group INC on April 15, 2025, according to a Form 4 filing.
NYSE
Director David Barr acquired 35 shares of TransDigm Group INC common stock on March 26, 2025, in lieu of a semi-annual director fee.
NYSE
Director Jane M. Cronin acquired 27 shares of TransDigm Group INC common stock in lieu of a semi-annual director fee on March 26, 2025.
NYSE
Director Sean P. Hennessy acquired 35 shares of TransDigm Group INC common stock in lieu of director fees on March 26, 2025.
NYSE
Michele Santana, a director at TransDigm Group INC, acquired 27 shares of common stock in lieu of a semi-annual director fee on March 26, 2025.
NYSE
Director Jorge L. Valladares III acquired 27 shares of TransDigm Group INC common stock in lieu of a semi-annual director fee on March 26, 2025.
NYSE
Director Michael Graff acquired 27 shares of TransDigm Group INC common stock in lieu of a semi-annual director fee.
NYSE
Director Robert Small acquired 42 shares of TransDigm Group INC common stock in lieu of director fees on March 26, 2025.
NYSE
Form 4: TransDigm Group INC: Co-Chief Operating Officer Joel Reiss Executes Stock Option and Sells Shares
Joel Reiss, Co-Chief Operating Officer of TransDigm Group INC, exercised stock options and sold shares on March 20, 2025, according to a Form 4 filing with the SEC.
NYSE
Director W. Nicholas Howley exercised stock options and sold shares of TransDigm Group INC on March 17, 2025, according to a recent SEC filing.
NYSE
Robert Small, a director at TransDigm Group INC, reported the sale of common stock in multiple transactions on March 13th and 14th, 2025.
NYSE
TransDigm Group's President and CEO, Kevin M. Stein, exercised stock options and sold shares on March 12, 2025, according to a recent SEC Form 4 filing.
NYSE
Director Robert Small reports the sale of TransDigm Group INC shares held indirectly through Stockbridge Partners LLC and Stockbridge Fund, L.P.
NYSE
Director Robert Small reports the sale of TransDigm Group INC shares held indirectly through Stockbridge Partners LLC and Stockbridge Fund, L.P.
NYSE
Jessica L. Warren, GC, CCO, and Secretary of TransDigm Group INC, exercised stock options and sold shares of common stock on March 4, 2025.
NYSE
Joel Reiss, Co-Chief Operating Officer of TransDigm Group INC, reports the exercise of stock options and subsequent sale of common stock on February 20, 2025.
NYSE
Director W. Nicholas Howley exercised stock options and sold shares of TransDigm Group INC on February 18, 2025, according to a Form 4 filing with the SEC.
NYSE
Director Robert J. Small exercised stock options and sold shares of TransDigm Group INC on February 14, 2025.
NYSE
CEO Kevin Stein exercised stock options and sold shares of TransDigm Group INC on February 12, 2025, according to a recent SEC Form 4 filing.
NYSE
TransDigm Group's Co-Chief Operating Officer, Joel Reiss, exercised stock options and sold shares on January 21, 2025, according to a recent SEC filing.
NYSE
Director W. Nicholas Howley exercised stock options and sold shares of TransDigm Group INC on January 15, 2025, according to a recent SEC filing.
NYSE
TransDigm Group's CEO, Kevin Stein, exercised stock options and sold shares on January 13, 2025, according to a recent SEC filing.
NYSE
Form 4: TransDigm Group INC: Co-Chief Operating Officer Joel Reiss Executes Stock Option and Sells Shares
Joel Reiss, Co-Chief Operating Officer of TransDigm Group INC, exercised stock options and sold shares on December 20, 2024, according to a Form 4 filing with the SEC.
NYSE
TransDigm Group INC director W. Nicholas Howley exercised stock options and sold shares held indirectly through a family trust on December 16, 2024.
NYSE
TransDigm Group's CEO, Kevin M. Stein, exercised stock options and sold a significant number of shares held in a trust on December 12, 2024.
NYSE
Director Robert J. Small of TransDigm Group INC sold a total of 38,053 shares of common stock across multiple transactions on December 12, 2024.